Evidence map›Paper›PMID 19570724›Full record

ReviewJournal of pediatric urology2009

Controversies in the management of vesicoureteral reflux: the rationale for the RIVUR study.

Ranjiv Mathews, Myra Carpenter, Russell Chesney, Alejandro Hoberman, Ron Keren, Tej Mattoo, Marva Moxey-Mims, Lee Nyberg, Saul Greenfield

Registry-linked trialAbstract readReview
In one paragraph

Review in Journal of pediatric urology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00405704 (Randomized Intervention for Children With Vesicoureteral Reflux), which is not on this map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
10.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00405704 phase3completednot on this map

Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR)

TypeinterventionalSponsorNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Ran2007 to 2014Enrolled607ConditionsVesicoureteral Reflux, Urinary Tract InfectionsArmsTrimethoprim-Sulfamethoxazole, Placebo
3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 48 citations in OpenAlex.

  1. Does the presence of non-refluxing hydroureter impact the management and outcome of high-grade hydronephrosis?Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2020
    Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Learning from history or the rationale for considering surgical correction of vesicoureteral reflux.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2010
    Article
  11. Medical versus surgical management for vesicoureteric reflux: the case for medical management.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2010
    Article
  12. Article
  13. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Ranjiv MathewsDivision of Pediatric Urology, The Johns Hopkins School of Medicine, Baltimore, MD 21287, USA. rmathew1@jhmi.edu
Myra Carpenter
Russell Chesney
Alejandro Hoberman
Ron Keren
Tej Mattoo
Marva Moxey-Mims
Lee Nyberg
Saul Greenfield
Johns Hopkins University · USJohns Hopkins Medicine · US

Funding

Randomized Intervention for Vesico-Ureteral Reflux (RIVUR) TrialU01DK074082 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI WANG, MING-HSIEN · 2005 to 2012
$2.5M
NIDDK NIH HHS U01 DK074082
6 · The paper itself

Abstract

unlabelledThe current management of vesicoureteral reflux (VUR) focuses on the prevention of urinary tract infections (UTI), with curative surgery being limited to those children that fail conservative measures. This is based on the assumption that UTIs are preventable with the use of prophylatic antibiotics, leading to reduction of renal scarring, and the possibility that VUR in children can resolve spontaneously.

methodsReview of the recent literature has demonstrated a growing concern that antibiotic prophylaxis may not lead to prevention of UTIs. Additionally, data indicate that renal scarring may not be preventable with antibiotic prophylaxis or even surgical correction of VUR. An overview of all of the current controversies is presented in this paper.

resultsDoes antibiotic prophylaxis lead to reduction in UTIs in children with VUR? To address this question, the National Institutes of Health have developed a randomized placebo-controlled study of children with VUR (the RIVUR Study), identified following the development of a UTI.

conclusionsThere are far reaching consequences of the results of the RIVUR Study. If antibiotic prophylaxis does not prevent UTI in children with VUR, or lead to reduction in renal scarring, does identification of VUR provide any benefits? Perhaps appropriate treatment of UTI may be all that is necessary for preserving renal function. Final answers will have to wait until the completion of this study.

Indexed as

ChildHumansUrinary Tract InfectionsVesico-Ureteral Reflux

Identifiers

PMID19570724
PMCPMC3163089
OpenAlexW2156998936

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.